Read more

Post 100 crore vaccination milestone, Union health minister Mansukh Mandaviya has called for a meeting with all the state health ministers at Delhi’s Vigyan Bhawan on Wednesday. This is to expedite vaccinations for those with pending second dose and those who still have not taken their first dose.

Meanwhile, the World Health Organisation (WHO) has asked for additional clarifications from Bharat Biotech for its Covid-19 vaccine Covaxin to conduct a final ‘risk-benefit assessment’ for Emergency Use Listing (EUL) of the vaccine. The technical advisory group will now meet on November 3 for a final assessment. Hyderabad-based Bharat Biotech had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine’s Emergency Use Listing (EUL).

The United States has moved a step closer to expanding Covid-19 vaccinations for children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer’s shots for 5 to 11-year-olds, AP reported.

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks. While children are far less likely than older people to get severe COVID-19, ultimately many panelists decided it’s important to give parents the choice to protect their youngsters — especially those at high risk of illness or who live in places where other precautions, like masks in schools, aren’t being used.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.